SCHEMBL30209010

SCHEMBL30209010

Cc1cc(C(=O)O)c(=O)n(-c2cccc(F)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 5/20 0.57
ALDH1A1 P00352 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KDM4E B2RXH2 3/20 0.45
HPGD P15428 1/20 0.45
LMNA P02545 1/20 0.44
SCN2B O60939 2/20 0.41
SCN1B Q07699 2/20 0.41
SCN5A Q14524 2/20 0.41
SCN9A Q15858 2/20 0.41
SCN1A P35498 1/20 0.41
FAAH O00519 1/20 0.40
MGLL Q99685 1/20 0.40
MET P08581 1/20 0.40
AXL P30530 1/20 0.40
TYRO3 Q06418 1/20 0.40
MERTK Q12866 1/20 0.40
KMT2A Q03164 1/20 0.39
DHODH Q02127 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21786023 1.00 NOTUM (0.57) NOTUMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL679402 0.85 KDM4E (0.57) NOTUMALDH1A1KDM4EHPGDLMNA
SCHEMBL679241 0.84 LMNA (0.57) NOTUMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL21785514 0.84 ALDH1A1 (0.49) NOTUMALDH1A1L3MBTL1KDM4EHPGD
SCHEMBL30208868 0.82 ALDH1A1 (0.52) NOTUMALDH1A1KDM4EHPGDLMNA
SCHEMBL21786022 0.82 ALDH1A1 (0.52) NOTUMALDH1A1KDM4EHPGDLMNA
SCHEMBL24878824 0.76 L3MBTL1 (0.45) NOTUMALDH1A1L3MBTL1SCN2BSCN1B
SCHEMBL1259527 0.73 NOTUM (0.66) NOTUMALDH1A1L3MBTL1KDM4ELMNA
Fluorofenidone SCHEMBL1047536 0.73 ALDH1A1 (0.64) NOTUMALDH1A1L3MBTL1KDM4EHPGD
Fluorofenidone SCHEMBL29420525 0.73 ALDH1A1 (0.64) NOTUMALDH1A1L3MBTL1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780835-B2 Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases ARRAY BIOPHARMA INC. (US) 2023-10-10 US disclosed
US-20230011441-A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES ARRAY BIOPHARMA INC. (US) 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230011441-A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES RET, MERTK, MET NOTUM 4690/4885ALDH1A1 2121/4885L3MBTL1 1756/4885
US-11780835-B2 Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases RET, MERTK, MET NOTUM 4690/4885ALDH1A1 2121/4885L3MBTL1 1756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.